Académique Documents
Professionnel Documents
Culture Documents
Abstract:
In the present work a new method development and validation was carried out for the estimation
of Amlodipine besylate and Hydrochlorthiazide by RP-HPLC technique. The wavelength
selection was made at 245 nm in various literature were having a maximum absorbance at
around 240 to 250 nm. Hence the wavelength was selected at 245 nm for the detection of the
compound. For the method development several trials were carried out and reported. These
leads to the optimized chromatographic conditions for the estimation of Amlodipine besylate
and Hydrochlorthiazide pharmaceutical dosage form. Preliminary studies involved trying C 18,
columns and several mobile phase compositions for the effective separation of these drugs. by
Symmetry C18 Hypersil-BDS column eluted with mobile phase Degassed water and acetonitile
at a flow rate of 1.0ml/ min and a detection wavelength of 245 nm with injection volume of 20
^l at ambient(25°C) temperature afforded the best results. The chromatograms of trial methods
were as shown.
AMLODIPINE
A thiazide diuretic often considered the prototypical member of this class. It reduces the
reabsorption of electrolytes from the renal tubules. This results in increased excretion of water
and electrolytes, including sodium, potassium, chloride, and magnesium. It has been used in
the treatment of several disorders including edema, hypertension, diabetes insipidus, and
hypoparathyroidism.
HYDROCHLORTHIAZIDE
HPLC : The modern form of column chromatography has been called high performance,
high pressure, and high-resolution and high-speed liquid chromatography. High-Performance
Liquid Chromatography (HPLC) is a special branch of column chromatography in which the
mobile phase is forced through the column at high speed. In 1960’s chromatographers started
modifying the polar nature of silanol group by chemically reacting silica with organic silanes.
The objective was to make less polar or non polar so that polar solvents can be used to separate
water-soluble polar compounds. Since the ionic nature of the chemically modified silica is now
reversed i.e. it is non-polar or the nature of the phase is reversed. The chromatographic
separation carried out with such silica is referred to as reversed- phase chromatography
Instruments:
METHOD VALIDATION
SYSTEM SUITABILITY: After method development, the validation of the current method
has been performed in accordance with USP requirements for assay determination (Category-
I: analytical methods for quantitation of active ingredients in finished pharmaceutical products)
which include accuracy, precision, selectivity, linearity and range, robustness and ruggedness.
Data of System Suitability for Amlodipine besylate
Peak
Injection RT Area USP Plate count USP Tailing
SD 0.0075 0.8365
SD 0.0147 2.6214
PRECISION:
The precision of the analytical method was determined by assaying sufficien number of sample
and relative standard deviation was calculated.
(a) System precision:
Data of Repeatability (System precision) for Amlodipine besylate
Peak Areas of
Injection Amlodipine besylate
%Assay
1 142 99.92
4 141 99.33
5 141 98.98
1 998 100.06
Concentration
2 999 100.17
40ppm
3 997 99.96
4 999 100.21
5 999 100.20
5.3.4 REPEATABILITY
TABLE-12: Data of Repeatability (Method precision) for Hydrochlorothiazide
Peak Areas of
Injection Hydrochlorothiazide
%Assay
1 998 100.04
4 999 100.20
5 997 99.96
6 999 100.13
ACCURACY (RECOVERY)
The accuracy of an analytical method is the closeness of that results obtained by that method
to the true value. Accuracy may often be expressed as percent recovery by the assay of known
added amount of analyte
Data of Accuracy for Amlodipine besylate
Concentration Amount Amount Statistical
% of spiked added found % Analysis of %
level (ppm) (ppm) Recovery
Recovery
50%
20 19.96 99.80 MEAN 99.95
Injection 1
50%
20 19.83 99.15
Injection 2
50%
20 20.18 100.90 %RSD 0.89
Injection 3
100 %
40 39.76 99.40 MEAN 99.84
Injection 1
100 %
40 39.95 99.87
Injection 2
100%
40 40.10 100.25 %RSD 0.43
Injection 3
150%
60 59.65 99.42 MEAN 99.64
Injection 1
150%
60 59.78 99.63
Injection 2
150%
60 59.93 99.88 %RSD 0.23
Injection 3
Data of Accuracy for Hydrochlorothiazide
Concentration Amount Amount
% of spiked added found % Statistical Analysis
50%
20 19.97 99.85 MEAN 99.88
Injection 1
50%
20 19.96 99.80
Injection 2
50%
20 20.00 100.00 %RSD 0.10
Injection 3
100 %
40 40.03 100.07 MEAN 100.07
Injection 1
100 %
40 39.99 99.97
Injection 2
100%
40 40.05 100.17 %RSD 0.10
Injection 3
150%
60 60.08 100.13 MEAN 100.07
Injection 1
Injection 2 60 60.03 100.05
150%
60 60.02 100.03 %RSD 0.053
Injection 3
LINEARITY:
The linearity of the analytical method for assay by injecting the various concentrations of
standard preparations prepared The linearity between the peak-area and the concentration was
examined
Assay % of Amlodipine
S.NO: Peak area
besylate
1 142 99.92
2 140 98.63
3 142 99.97
4 144 101.42
5 143 100.68
6 142 100.08
Hydrochlorothiazide
1 998 100.06
2 997 100.01
3 999 100.13
4 997 100.00
5 999 100.17
6 998 100.10
Mean 998.5715 100.08
Robustness:
Data for Effect of variation in flow rate (Amlodipine besylate):
Flow Std Taili Flow Std Taili Flow Std Taili
0.8 ml Area facto 1.0 ml facto 1.2 ml facto
ng Area ng Area ng
201.245 r1.06 142.9 r0.97 119.5 r0.86
202.273
8 1.06
54 141.7
203 0.96
45 121.6
373 0.86
77
198.793
5 1.06
66 143.6
788 0.98
56 121.8
676 0.85
56
203.170
8 1.04
59 139.4
957 0.97
24 120.6
238 0.87
55
202.936
5 1.02
32 143.7
545 0.97
52 119.5
342 0.86
46
Avg 9201.684 36
1.05 Avg 142.3
711 0.97
51 Avg 120.6
126 0.86
56
SD 1 1.78 0.01
29 SD 1.79
241 0.00
46 SD 1.11
351 0.00
58
%RS 0.88 91.8 %RS 1.26
3 60.6 %RS 0.92
2 70.8
D 0 D 1 D 1
Data for Effect of variation in flow rate (Hydrochlorothiazide):
Flow Std Taili Flow Std Area Taili Flow Std Area Taili
0.8 ml factor facto
Area ng 1.0 ml ng 1.2 ml factor
ng
1324.54 0.829 998.790 r0.761 831.943 0.655
1322.42
69 0.813
5 999.529
5 0.752
2 830.773
7 0.659
5
1323.67
99 0.834
3 998.393
1 0.763
2 829.434
3 0.649
8
1323.60
87 0.826
5 997.456
0 0.775
2 830.474
6 0.665
4
1322.13
45 0.826
7 999.045
6 0.766
6 830.838
3 0.649
4
Avg 1323.27
27 0.826
6 Avg 998.643
7 0.763
2 Avg 830.692
4 0.656
8
SD 0.988
85 0.007
1 SD 0 0.781 0.008
7 SD 9 0.898 0.006
0
%RSD 0.074 0.944
8 %RSD 0.078 1.099
4 %RSD 0.108 1.036
8
BIBLIOGRAPHY
1. D. N. Vora and A. A. Kadav. Development and Validation of a Simultaneous HPLC Method for
Estimation of Bisoprolol Fumarate and Amlodipine Besylate from Tablets. Indian J Pharm Sci.
2008 Jul-Aug; 70(4): 542-546. doi: 10.4103/0250- 474X.44616.
3(11),2647-2650
17. Delhiraj N and Anbazhagan S. validated chromatographical methods for the simultaneous
estimation of antihypertensive drugs in pharmaceutical dosage forms. Int J Pharm 2013;
3(1):103-107
18. Ravisankar Panchumarthy, Devala Rao Garikapati . An Improved Rapid HPLC Method for the
Separation of Five Anti-Hypertensive Agents Using C18 Column: Application to
Hydrochlorothiazide Determination in Bulk and Tablet Dosageform. IOSR Journal Of Pharmacy. Volume 3,
Issue 5 (June 2013), Pp 07-19
19. Naman doshi, Avani sheth, C N Patel. Validated reverse phase high performance liquid
chromatographic method for simultaneous estimation of olmesartan medoxomil,
hydrochlorothiazide and amlodipine besylate in newly designed pharmaceutical dosage
form. International research journal of pharmacy.2012, 3(11).
20. Bheru S.Malviya*, Prince Shivhare, Pramod Hinnariya and Vidhi Jain. Development
and Validation of UPLC Method for Simultaneous Determination of Irbesartan,
Hydrochlorothiazide, Amlodipine Besylate and Atorvastatin. international journal of drug
discovery and herbal research (ijddhr) 2(4): Oct.-Dec.: (2012), 481-486.